Clinical Trials

Showing trials with last updates posted in 2021.

NCT05050630 | UNKNOWN | PHASE2
73 participants

Phase II Trial of Tirelizumab Combined With R2-ICE Regimen in the Treatment of rrDLBCL/HGBL

Study Type:
INTERVENTIONAL
Last Updated:
2021-09-20
Start Date:
2021-08-01
Completion:
2022-07-30
Conditions
  • Age Range ≥16 Years, Gender Unlimited
  • Histopathology Confirmed Diffuse Large B-cell Lymphoma or High-grade B-cell Lymphoma
  • Received Prior First-line Chemotherapy for DLBCL or HGBL, Failed to Reach CR for Four Cycles, or Relapsed
  • At Least One Positive Lesion According to the 2014 Lugano Criteria for Hodgkin's and Non-Hodgkin's Lymphoma
  • ECOG Physical Status Score is 0-3
  • The Researchers Judged That Life Expectancy Was at Least Three Months
  • Understand and Voluntarily Sign Written Informed Consent
Interventions
  • DRUG
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page